Cytisine versus varenicline for smoking cessation in a primary care setting: a randomized non-inferiority trial
<p><strong>Introduction: </strong>A smoking-cessation program was implemented as a randomized non-inferiority trial in primary care practices in Croatia and Slovenia to investigate whether a standard 4-week treatment with cytisine was at least as effective and feasible as a standar...
Hauptverfasser: | Oreskovic, T, Percac-Lima, S, Ashburner, JM, Tiljak, H, Rifel, J, Klemenc Ketiš, Z, Oreskovic, S |
---|---|
Format: | Journal article |
Sprache: | English |
Veröffentlicht: |
Oxford University Press
2023
|
Ähnliche Einträge
Ähnliche Einträge
-
Smoking cessation 3: Nicotinic partial agonists in smoking cessation - Varenicline and cytisine
von: Aveyard, P, et al.
Veröffentlicht: (2009) -
An integrated approach to pharmacotherapy in smoking cessation: the role of varenicline, bupropion, cytisine, and nicotine replacement therapy
von: Kacper Więcław, et al.
Veröffentlicht: (2023-08-01) -
Could APO-varenicline and cytisine be solutions for the shortage of varenicline in Brazil?
von: Paulo César Rodrigues Pinto Corrêa, et al.
Veröffentlicht: (2023-06-01) -
What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation
von: Joanna Leaviss, et al.
Veröffentlicht: (2014-05-01) -
Placebo-controlled trial of cytisine for smoking cessation.
von: West, R, et al.
Veröffentlicht: (2011)